Meet Eve: she's darn smart, can make the process of finding new drugs a lot faster and cheaper -- and she costs around $1 million. That's because Eve is a robotic scientist developed by researchers from the Universities of Aberystwyth and Cambridge, the same team who created her predecessor (you guessed it) Adam back in 2009. Since Eve was created specifically to automate the early stages of drug design, she's capable of scanning over 10,000 compounds a day, whereas humans obviously wouldn't be able to process as many in the same timeframe. As Professor Ross King from the University of Manchester (which Eve calls home) said: "Every industry now benefits from automation and science is no exception. Bringing in machine learning to make this process intelligent -- rather than just a 'brute force' approach -- could greatly speed up scientific progress and potentially reap huge rewards."